US 12071434
Heterocyclic compound
granted A61PA61P25/26A61P43/00
Quick answer
US patent 12071434 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P25/26, A61P43/00